Higher doses may increase gastrointestinal side effects without improving outcomes
In the phase 3 study REDEFINE 1 (about 3417 adults with obesity without diabetes, 68 weeks), the cagrilintide + semaglutide combination produced a mean weight reduction of 20.4% , versus 11.5% for cagrilintide alone, 14.9% for semaglutide alone and 3.0% for placebo
Given the positive preclinical results and the growth of our aging populations, it is imperative to advance GH-RH antagonists into clinical trials to improve BPH outcomes
Mounjaro helps in weight loss by helping reduce food intake and slowing gastric emptying, leading to significant weight reduction
A small number of users report feeling overly relaxed or sedated if taking DSIP too early in the evening, leading to difficulty staying awake until intended bedtime
Peptide Vials (BPC-157, 10 mg each): 8 weeks 3 vials (25.2 mg used) 12 weeks 5 vials (42 mg used) 16 weeks 6 vials (58.8 mg used) Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution
